Follow-up of treated acromegaly: Similarities and differences in assessing the response to different primary treatment modalities

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. B, 2000, Pages

  Sheppard, M C ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Acromegaly; Insulin like growth factor I; Outcome; Treatment

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOPITUITARISM; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RELAPSE; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033874179     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(00)80022-2     Document Type: Review

References (13)

1. Mortality in acromegaly
2. Epidemiology of acromegaly in the Newcastle region
3. Acromegaly
4. Epidemiology and long term survival in acromegaly
5. Mortality and cancer incidence in acromegaly: A retrospective cohort study
6. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors
7. Growth hormone pulsatility in acromegaly following radiotherapy
8. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly
9. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results
10. Determinants of clinical outcome and survival in acromegaly
11. Growth hormone, body composition and somatomedin C after treatment of acromegaly
12. An audit of outcome of treatment in acromegaly
13. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly